News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Invitrogen Corporation (IVGN) Receives Approval from Health Canada for System to Help Determine Organ Transplant Compatibility


1/13/2009 9:21:02 AM

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced that its DynaChip® HLA Antibody Analysis System has received approval from Health Canada’s Medical Device Bureau for the detection and identification of antibodies to human leukocyte antigen (HLA) markers, which is an essential step in determining the compatibility of organ donors.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES